University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Other Publications in Zoonotics and Wildlife
Disease

Wildlife Disease and Zoonotics

1995

Infections Associated with Bartonella Species in Persons Infected
with Human Immunodeficiency Virus
Russell L. Regnery
Centers for Disease Control and Prevention

James E. Childs
james.childs@yale.edu

Jane E. Koehler
University of CaliforniaA IDS Research Program

Follow this and additional works at: https://digitalcommons.unl.edu/zoonoticspub
Part of the Veterinary Infectious Diseases Commons

Regnery, Russell L.; Childs, James E.; and Koehler, Jane E., "Infections Associated with Bartonella Species
in Persons Infected with Human Immunodeficiency Virus" (1995). Other Publications in Zoonotics and
Wildlife Disease. 54.
https://digitalcommons.unl.edu/zoonoticspub/54

This Article is brought to you for free and open access by the Wildlife Disease and Zoonotics at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Other Publications in
Zoonotics and Wildlife Disease by an authorized administrator of DigitalCommons@University of Nebraska Lincoln.

S94

InfectionsAssociatedwith BartonellaSpecies in Persons Infected with Human
ImmunodeficiencyVirus
Russell L. Regnery, James E. Childs,
and Jane E. Koehler

From the Viral and RickettsialZoonoses Branch, Division of Viraland
RickettsialDiseases, Centersfor Disease Control and Prevention,
Atlanta, Georgia; and the Division of InfectiousDiseases, Universityof
California,San Francisco, California

Two membersof the genus Bartonella,Bartonellaquintana(formerlyRochalimaeaquintana)and
Bartonella henselae (formerlyRochalimaeahenselae), have recently been recognizedas agents of
severeor fatal disease in patients infectedwith human immunodeficiencyvirus (HIV). The development of infection with B. henselae in HIV-infectedindividualshas been associatedwith traumatic
contact with cats (scratches or bites), and domestic cats have been identifiedas a major reservoir
for this organism.Specific informationregardingthe transmissionof B. henselae to humans is not
yet available, but common-senseprecautionsthat minimize exposure to cat-associatedorganisms
are appropriate.Preliminaryaccounts suggest that B. quintana infections are more common than
B. henselae infections among HIV-infectedindividuals in San Francisco. The source of infection
with B. quintana and the mechanismof its transmissionremain unknown.

The four species of the genus Rochalimaea(Rochalimaea
quintana, Rochalimaeahenselae, Rochalimaeaelizabethae,
and Rochalimaeavinsonii)were recentlyshownto be closely
relatedto the sole memberof the genusBartonella(Bartonella
bacilliformis)[1]. Because Bartonellawas describedbefore
Rochalimaea,the formerdesignationtakesprecedenceoverthe
latter.Thusthe nameBartonellawill be used in this document
to describeall five membersof the expandedgenus.However,
in manypublicationsthe nameRochalimaeamay still be used.
Species names remainunchanged;e.g., R. henselae is now
knownas Bartonellahenselae.

Background
The diseasesknownto be associatedwithBartonellaspecies
are listed in table 1. Historically,the best-knownmemberof
the genus is Bartonellaquintana,the bacteriumthat caused
trench fever in World War I [2]. In 1990, DNA sequences
closely relatedto B. quintanawere identifiedin the lesions
of patientswith bacillaryangiomatosis(BA) [3], a vascular
proliferativedisorderthat occursin HIV-infectedpersons[4].
Independently,a fastidious gram-negativerod was isolated
fromHIV-infectedpatientswith a relapsingfebrileillness [5],
and similarbacilli were noted in tissue frompatientswith an
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unusualhepaticdiseaseknownas peliosis hepatis[6]. A novel
species,B. henselae,was laterisolatedand fully characterized
[7, 8]. GenesequencesfromB. henselaewereidenticalto those
previouslyidentifiedin biopsiedtissuesfrompatientswith BA
andpeliosishepatis[3, 7]. The subsequentisolationof bacteria
directlyfrom cutaneouslesions of BA revealedthat eitherB.
henselae or B. quintanacan cause this disease [9]. Over the
past decade, since BA was first describedby Stoleret al. in
New York City [10], the spectrumof bartonellainfectionin
patientswith concomitantHIV infectionhas been expanding;
now includedareendocarditis[11, 12] andangiomatouslesions
involvingmanyorgans,includingthe skin, liver, lung, spleen,
bone,andbrain.(Fora summaryof the involvementof various
organs,see [13].) AlthoughcutaneousBA can be an indolent
diseasewith remissionsand exacerbationsover many months
[4], its systemicsymptomscanbe debilitating.Whenbartonella
infectionremainsundiagnosedin patientswith HIV infection,
it can be fatal [14].
Recently,B. henselae was found to be the cause of catscratchdisease [15-17] in additionto some cases of BA. The
reason for the different host responses to infection with
in the immunocompetent
host and
B. henselae(granulomatous
vascularproliferativein the immunocompromised
host) is unknown. Immunocompetent
people with B. henselae infection
can developa prolongedfebrileandrelapsingillness [18] like
that seen in HIV-infectedpatients[5, 7].
Infectionwiththe remainingthreeBartonellaspecieshasnot
been reportedin HIV-infectedpatients.Bartonellaelizabethae
caused severe endocarditisin one immunocompetent
patient
[19]. No humaninfectionswith Bartonellavinsoniihave been
identified.B. bacilliformis,the etiologicagentof bartonellosis,
causes biphasicillness: the acute febrile phase is known as
Oroya fever, and the chronicphase with cutaneousvascular
lesions is known as verrugaperuana[20]. These cutaneous
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Table 1. Diseases with well-documented associations with Bartonella species.
Immunestatus,disease
Competent
Cat-scratchdisease
Trenchfever
Bartonellosis
Endocarditis
Compromised
Bacillaryangiomatosis
Relapsingbacteremiawith fever
Endocarditis

Causativespecies of Bartonella

B. henselae
B. quintana
B. bacilliformis
B. henselae,B. quintana,B. elizabethae
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hostsandthatcannotbe expectedto regressas long as antigenis
present.It is possiblethatpersonswith intactimmunesystems,
unlikeseverelyimmunocompromised
patients,sequesterviable
or antigenicallyactive Bartonellawithin either cells or immune-mediatedtissue complexes(e.g., granulomas).

Incidence

estimatesof theprevalenceof antibodyto BartoPreliminary
nella among apparentlyhealthy humansrange from 4% to
6% [15, 22]. Cat-scratchdisease is clinicallydiagnosedin an
estimated22,000 personseach year in the UnitedStates[23].
The incidenceof Bartonella-associateddisease among HIVinfectedpersonsis unknown.Theseinfectionsmaygo unrecogthose
of
from
are
sometimes
BA;
indistinguishable
eruptions
nized in the majorityof cases, andthe intervalbetweeninfechowever,infectionwithB. bacilliformishas beenreportedonly
tion andthe diagnosisof BA can covermonthsor even a year
in the Andes Mountainsof SouthAmerica[20].
Numerousreportsin the literaturedescribe good clinical
personsmay
[9]. In addition,diseasein immunocompromised
BA
or
with
of
peliosis
representreactivationof infectionratherthanprimaryinfection:
patients
responses immunocompromised
low-titerantibodiesto Bartonellahave been documentedin
hepatisto treatmentwith erythromycinor doxycycline.In the
sera obtainedfrom HIV-infectedpeople before the
banked
one
of
the
authors
of
(J.E.K.),erythromycin,doxyexperience
in
been
successful
and
have
diagnosis of BA, with increasedtiters at the time of diagcycline, tetracycline, minocycline
and
nosis
the treatmentof these conditions(table2) [13]. Rifampin
[24].
Bartonellainfectionsin HIV-infectedpeople often are not
gentamicinappearto have some clinical efficacy; although
there is insufficientevidenceto recommendthe use of either recognizedfora numberof reasons.First,cutaneousBA lesions
fromKaposi'ssarcoma[25];
canbe clinicallyindistinguishable
agentalone,these drugsmay be of value when combinedwith
a first-lineagent for the treatmentof immunocompromised in these cases, BA can be distinguishedonly by biopsy with
vascularproliferdisease(e.g., osteohistopathologicexamination.A characteristic
patientswith severeBartonella-associated
infiltrateis evidentuponhemyelitis,peliosishepatis,or endocarditis).Thereareconflicting ationwith a mixed inflammatory
reportsregardingthe responseof BA lesions in immunocom- matoxylinandeosin stainingof biopsiedBA tissue, andbacilstaining
by Warthin-Starry
laryorganismscanbe demonstrated
promisedpatientsto treatmentwith quinolones[13].
The optimaldurationof treatmentfor immunocompromised [4]. Second, hepaticdisease caused by Bartonellaspecieseven the relativelydramaticform, peliosis hepatis-can be
individualsis unknown,butpatientswith cutaneousBA should
fromotherinfectiousor malignantconditions
receive an appropriateantibioticfor at least 2 or 3 months; indistinguishable
cause
that
severe
disease
with
more
hypodenselesions demonstrableby abdominalCT
(osteomyelitis,peliosis heppatients
4
months
of
antibiotic
or
minimum
of
3
receive
a
should
pneumo(e.g., lymphoma,Kaposi'ssarcoma,extrapulmonary
atis)
therapy.Mostpatientstreatedwithtetracyclineor erythromycin cystosis, and bacterialand fungalabscesses).Third,clinicians
for4 monthsdo nothavea relapse.However,like salmonellosis evaluatingHIV-infectedpatientsmay fail to considerBartoand variousotherbacterialinfections,bartonellainfectioncan
relapsein some cases even afterprolongedtherapywith erythpatientswith bartonellainromycin[9]. Immunocompromised
withbacilindividuals
Table2. Clinicalresponseof HIV-infected
fection should be followed closely if antibiotictreatmentis
treatment
orpeliosishepatisto antibiotic
(SanFranlaryangiomatosis
at San Francisco,
of California
stoppedafter 4 months;if a relapseoccurs,these individuals cisco GeneralHospital/University
1987-1995).
shouldbe treatedindefinitelywith suppressiveantibiotics.
is
dramatic
to
antibiotics
the
clinical
response
Although
None
Inconclusive
Possible
Definite
patientswithbartonellainfection,
amongimmunocompromised
the responseof people with intactimmunesystems and catPenicillin
Ciprofloxacin
Erythromycin Gentamicin
Penicillin
Ceftriaxone
scratchdiseaseor relapsingbacteremiaremainsequivocal[18,
Rifampin
Doxycycline
derivatives
on
immune
status
the
of
host's
The
influence
curious
21].
Firstgeneration
Trimethoprim/
Tetracycline
to
manifesbe
related
different
antibiotic
efficacymay
apparent
sulfamethoxazole
cephalosporins
tationsof the syndromes.Cat-scratchdisease is clinically deMinocycline
fined by swollen lymph nodes and granulomatouslesionssigns that cannot develop in severely immunocompromised NOTE. Tableis adaptedwith permissionfrom [13].
B. henselae,B. quintana
B. henselae,B. quintana
B. henselae,B. quintana

S96

Regnery, Childs, and Koehler

Table 3. Manifestationsof bartonellainfections in HIV-infected
patients.

Bone
Lymphnode
Heart
Blood
Liver/spleenbacillary
peliosis

Other

tions of specificityand sensitivityfor the variousBartonellaassociatedsyndromesare necessary.

Manifestation

Organ
Skin (bacillary
angiomatosis)

CID 1995;21 (Suppl 1)

Diversepresentations,includinglesions
resemblingKaposi'ssarcoma,angiomatous
nodules,friablevascularlesions, red papules,
pedunculatedlesions, and deep subcutaneous
masses
Extremelypainfulosteolysis,lytic lesions on
radiography(positivetechnetiumscan)
Enlargement
Valvularvegetation,fever, weight loss
Fever,thrombosis
on CT,
Hypodenselesions, hepatosplenomegaly
elevatedvalues in liver functiontests (e.g.,
alkalinephosphatase),pancytopenia,
thrombocytopenia
Involvementof brain,gastrointestinal
tract,
lungs, etc.

NOTE. Tableis adaptedfrom [26].

nella in the differential diagnosis of a febrile illness in the
absence of cutaneous lesions or peliosis hepatis (table 3) [26].
Finally, culture of Bartonella species is difficult, requiring
special media and techniques. This situation compounds the
problems encountered in the diagnosis of isolated bartonella
bacteremia, even when this diagnosis is considered. A genusspecific IgG indirect fluorescent antibody (IFA) test recently
developed at the Centers for Disease Control and Prevention
(CDC) is both sensitive and specific for the confirmation of a
diagnosis of cat-scratch disease [15, 22]. Patients with catscratch disease typically have elevated titers of Bartonellaspecific IgG antibody at the time of their presentation to the
health care practitioner;titers appear to diminish within a year
of the original diagnosis [22]. The diagnosis of cat-scratch
disease by IFA test has correlated well (98%; 55 of 56 cases)
with clinical diagnosis and skin testing [27], and the specificity
of the IFA test is -95% [15, 22]. An IgM ELISA has also
shown relatively good sensitivity (95%; 53 of 56 cases) in
studies of patients with cat-scratch disease diagnosed by skin
testing; however, the specificity of the ELISA was only 77%
(43 of 56 cases) [27]. Preliminary results suggest that the IFA
test shows promise in the laboratoryconfirmation of bartonella
infections in HIV-infected patients [24]. Improved diagnostic
tests will result in more accurate assessment of the true incidence of bartonella infection in this population and may
facilitate appropriate treatment. Reagents for IFA testing for
Bartonella are currently available to regional and state health
laboratories from the CDC. Additional diagnostic techniques
for the serological testing of patients (including commercial
tests) are being developed. However, before their widespread
use as diagnostic tools, additional blinded, side-by-side evalua-

Source of Infection and Risk Factors
Numerousanecdotalreportshave describedexposureto and
contactwith cats before the developmentof BA in immunocompromisedpatients[13]. A case-controlanalysisfoundthat
riskfactor
recentcontactwith cats was the only environmental
associatedwith BA [28]. Patientswith BA-but not control
patients-were statisticallymore likely to have been licked,
scratched,or bittenby a cat beforedevelopingthis illness. The
amountof time spentwith a cat was associatedwiththe degree
of risk.As had previouslybeen documentedin studiesof catscratchdiseasein HIV-uninfected
populations[22, 29], ownerof
kittens
or
cats
those <1 year old) posed a
(i.e.,
young
ship
risk
HIV-infected
to
persons for acquiring
particularlyhigh
B. henselae-associateddisease [28].
It has recentlybeen shownthatthe domesticcat providesa
majorreservoirfrom which HIV-infectedpatientsapparently
acquireB. henselaeinfection.Sevenpet cats belongingto four
patientswith confirmedBA due to B. henselaehadthis organism isolated from the bloodstream,as did 25 (41%) of 61
randomlysampledcats in San Francisco[30]. Seroepidemiological studiesindicatethatB. henselaeinfectionof domestic
cats is also commonin otherregionsof the UnitedStates,with
a prevalenceof Bartonella-specificantibodiesrangingfrom
14%to 50%[22, 31]. An estimatedone-thirdof all households
in the UnitedStatesincludea cat [32], andcats may be persistentlybacteremicfor prolongedperiodswithoutobvioussigns
of illness [30, 33]. Thus,pet catspose a realbutprobablysmall
risk of B. henselaeinfectionto HIV-infectedowners[34].
Exposureto kittenswith fleas has been reportedto be a risk
factorfor cat-scratchdisease.Thus,it has been suggestedthat
arthropodvectors transmitB. henselae among felines and/or
betweenfelines andhumans,althougha cat scratchor bite has
been more stronglyassociatedwith acquisitionof the disease
[22]. Viable B. henselaebacilli have been isolatedfrom fleas
from cats [30], but the fleas' ability to transmitB. henselae
has not been established.Ticks also have been suggestedas
possiblevectorsof B. henselae [18, 22].
diseases,
Earlyin the investigationof Bartonella-associated
the humanbody louse (Pediculushumanus)was identifiedas
transmissionof B. quintana[2].
a vector of human-to-human
However,virtuallynothingis knownaboutpossiblearthropod
vectors or possible alternative vertebrate reservoirs of
B. quintana infections today. B. bacilliformis can be transmitted

by the sandfly(genus Phlebotomus)within its naturallyoccurringgeographicrange [20]. Neithernonhumanreservoirs
nor possible arthropodvectors of B. elizabethaeare known.
Because infections with B. bacilliformis and B. quintana can

it is plausiblethat othermembersof the
be arthropod-bome,
also have arthropodvectors.
B.
henselae)
genus (e.g.,

CID 1995;21 (Suppl 1)
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Theriskof developingrelativelyseverediseasedueto Bartonella species appearsto increaseas the CD4+ cell count decreases. In a recentreview, the mean CD4+ cell count of 15
disease was
HIV-infectedpatientswith Bartonella-associated
57/mm3[13]. In a case-controlstudyof 42 patientswith bartonella infection,patientswith BA were statisticallymorelikely
thancontrolsto have a CD4+ cell countof <200/mm3 [35].
Prevention
Physicians should recognize the potential psychological
valueof companionanimalsfor seriouslyill persons.However,
persons who have no prior emotional
immunocompromised
attachmentto a cat and who are concernedaboutthe risk of
B. henselae infection should consideralternativespecies for
companionship.Of course, the potentialfor zoonotic disease
associatedwith nonfelinecompanion-animal
species also must
be considered[34].
Because data are not yet availableon the degreeof risk to
humansfor B. henselae infectionrelatedto contactwith cats
or on the mode of B. henselae transmissionfrom one cat to
for
anotheror fromcats to humans,specificrecommendations
to
common-sense
limited
are
precautions
prevention currently
[34, 36]. Adult cats pose a lesser risk than do cats <1 year
old. Severely immunocompromisedpersons should avoid
roughplay with cats thatmightresultin scratchesor bites and
shouldnot allow a cat to lick opencuts or wounds.Contamination of broken skin with cat secretionsshould be avoided,
andcat-associatedwoundsshouldbe washedimmediatelywith
soap and water.Controlof fleas is appropriate.
Recommendations
regardingthe preventionof B. quintana
infectionarepresentlylimitedto the avoidanceof exposureto
the humanbody louse.
Research Priorities
disease amongHIV-infectedpersons
Bartonella-associated
has been describedonly recently,but it is alreadyevidentthat
treatmentand preventiveefforts can be beneficial.The incidence of Bartonella-associateddisease must be established,
and the spectrumof disease (includingsyndromescurrently
undiagnosed)must be more completelyelucidated.Economical, rapid,sensitive,and specificmethodsfor laboratorydiagnosis need to be furtherdevelopedand disseminatedto local
healthcarecenters.Thetiming,type,anddurationof antibiotic
prophylaxisfor initial or reactivatedbartonellainfection in
HIV-infectedpersons (especially those who are seropositive
for Bartonella)shouldbe considered.The developmentof microbialresistanceis a theoreticalpossibilityduringprolonged
antimicrobialtherapy.
Morecompleteanalysesof risk factorsfor infectionsdue to
B. henselaeandB. quintanamustbe undertaken.The routeby
which cats become infectedwith B. henselae and the way in
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whichthis organismpersistsin andis subsequentlytransmitted
by these animalsshouldbe established.The potentialfor the
eliminationof feline infectionsdueto B. henselaeby antibiotic
treatmentandforthe preventionof reinfectionmustbe studied.
A feline vaccine designed to preventB. henselae infection
shouldbe developed,with the interruptionof transmissionto
HIV-infectedpet owners as the ultimategoal. The possible
role of arthropodvectors in the transmissionof B. henselae
and B. quintananeeds to be clarified.
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